Sleep Fragmentation Linked to Worse Cognition in Midlife
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Jan. 3, 2024 -- High sleep fragmentation among younger adults is associated with worse cognition among middle-aged Black and White men and women, according to a study published online Jan. 3 in Neurology.
Yue Leng, Ph.D., from the University of California in San Francisco, and colleagues examined the association between sleep duration and quality among adults in their mid-30s to late 40s and midlife cognition assessed 11 years later. Sleep duration and quality were assessed objectively and subjectively in 2003 to 2005; midlife cognition was evaluated during 2015 to 2016.
Data were included for 526 participants (58 percent women; 44 percent Black), with a mean age of 40.1 ± 3.6 years at baseline. Overall, 45.6 percent of the participants reported poor sleep, defined as a Pittsburgh Sleep Quality Index global score >5. The researchers found that those in the highest versus the lowest tertile of the sleep fragmentation index had significantly increased odds of poor cognitive performance on the Digit Symbol Substitution Test, fluency, and Montreal Cognitive Assessment test (odds ratios, 2.97, 2.42, and 2.29, respectively) after adjustment for demographics, education, smoking, body mass index, depression, physical activity, hypertension, and diabetes. No difference was seen in the association between sleep fragmentation and cognitive performance by race or sex. No association was seen for objective sleep duration or subjective sleep quality with cognition in midlife.
"Our findings indicate that the quality rather than the quantity of sleep matters most for cognitive health in midlife and that the measures of sleep should go beyond self-report," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-04 08:15
Read more
- FDA Approves Vyalev for Advanced Parkinson Disease
- ICYMI, Txt Abbreviations Cn Make U Seem Insincere, Study Finds
- McDonald's Quarter Pounder Beef Patties Not Source of E. Coli Contamination
- Money, Education Helps Determine Your Odds for Dementia
- LENZ Therapeutics Announces FDA Acceptance of New Drug Application for LNZ100 for the Treatment of Presbyopia
- Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions